Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 3
2001 1
2004 1
2006 2
2008 1
2009 2
2010 2
2011 2
2012 3
2013 7
2014 1
2015 6
2016 13
2017 4
2018 6
2019 9
2020 10
2021 5
2022 8
2023 7
2024 6
2025 6
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
The impact of memory support strategies on patient recall for treatment content in individuals with and without cognitive impairment.
Milner AE, Woo C, Ge L, Oliver S, Kuo K, Marcotullio K, Varghese J, Bol K, Bae H, Tiab SS, Sarfan LD, Zieve GG, Carpenter JK, Harvey AG. Milner AE, et al. Among authors: bol k. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2026 May;33(3):296-316. doi: 10.1080/13825585.2026.2672375. Epub 2026 May 13. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2026. PMID: 42130034
The impact of memory support strategies on patient recall for treatment content in individuals with and without cognitive impairment.
Milner AE, Woo C, Ge L, Oliver S, Kuo K, Marcotullio K, Varghese J, Bol K, Bae H, Tiab SS, Sarfan LD, Zieve GG, Carpenter JK, Harvey AG. Milner AE, et al. Among authors: bol k. Res Sq [Preprint]. 2026 Mar 28:rs.3.rs-9152809. doi: 10.21203/rs.3.rs-9152809/v1. Res Sq. 2026. Update in: Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2026 May;33(3):296-316. doi: 10.1080/13825585.2026.2672375. PMID: 41928785 Free PMC article. Updated. Preprint.
Prospective study of patients with immune checkpoint inhibitor-induced hepatitis; characterization of liver injury, outcome of therapy, and management of steroid-unresponsive and steroid-dependent hepatitis.
Holmstroem RB, Teisner AS, Sweep MWD, Noringriis IM, Khan S, Aagaard NK, Karlström J, Jurlander RS, Sohlin JE, Monberg TJ, Vestergaard C, Stoltenborg Granhøj J, Stenbøg P, Toxvaerd A, Hansen AB, Bjerring PN, Lorentzen T, Thielsen P, Bol K, Jonsson G, Ellebaek E, Svane IM. Holmstroem RB, et al. Among authors: bol k. J Immunother Cancer. 2026 Mar 5;14(3):e013861. doi: 10.1136/jitc-2025-013861. J Immunother Cancer. 2026. PMID: 41786454 Free PMC article.
Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines.
Carrier A, Manghi P, Silva CAC, Lahmar I, Suissa D, Iebba V, Almonte AA, Ajami NJ, Birebent R, Laheurte C, Schreibelt G, Lemant L, Fahrner JE, de Sousa E, Berthier F, Villemonteix J, Chevalier MF, Piccinno G, Hocquet D, Lebhar I, Maeurer M, Caillat-Zucman S, Kobold S, Kroemer G, Derosa L, Launay O, Pieper DH, Vital M, Santos-Peral A, Zaucha M, García-Bengoa M, Thorn-Seshold J, Stirling H, Golden E, Bol KF, White MG, Sahasrabhojane PV, Hoballah YM, Losh JS, DePinho CR, Dondossola E, de Vries IJM, Adotevi O, Wargo JA, Rothenfußer S, Segata N, Formenti S, Zitvogel L. Carrier A, et al. Among authors: bol kf. Res Sq [Preprint]. 2025 Oct 28:rs.3.rs-4294379. doi: 10.21203/rs.3.rs-4294379/v1. Res Sq. 2025. PMID: 41282134 Free PMC article. Preprint.
Do Provider Characteristics and Perceptions Influence the Adoption and Implementation of the Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TSC) in Community Mental Health Centers?
Diaz M, Milner AE, Sarfan LD, Agnew ER, Oliver SM, Bol K, Harvey AG. Diaz M, et al. Among authors: bol k. Community Ment Health J. 2026 May;62(4):619-631. doi: 10.1007/s10597-025-01552-y. Epub 2025 Oct 31. Community Ment Health J. 2026. PMID: 41171520 Free PMC article.
Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses.
van Ravensteijn SG, de Haan JJ, Gelderblom H, Nederkoorn MJL, Hillebrandt-Roeffen MHS, Gorris MAJ, de Bitter TJJ, Boleij A, Gusinac A, Ederveen THA, Flucke UE, Bonenkamp JJ, Speetjens FM, Kaal SEJ, Smits M, Bol KF, van Herpen CML, Versleijen-Jonkers YMH, Desar IME. van Ravensteijn SG, et al. Among authors: bol kf. Clin Cancer Res. 2025 Sep 2;31(17):3678-3691. doi: 10.1158/1078-0432.CCR-25-0311. Clin Cancer Res. 2025. PMID: 40632032 Free PMC article. Clinical Trial.
100 results